Loss‐of‐Function Variants in CPT1C : No Support for a Causal Role in Hereditary Spastic Paraplegia
Movement Disorders · 2025
DOI: 10.1002/mds.70144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Rui Zhu und 17 weiteren Autor:innen. Beteiligte Einrichtung: The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Québec, Canada. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary, Carnitine O-Palmitoyltransferase, Loss of Function Mutation. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
Hereditary spastic paraplegias (HSPs) are neurodegenerative disorders characterized by lower‐limb spasticity. Pathogenic variants in CPT1C have been implicated in HSP.
Objective
The objective of this study was to assess whether CPT1C loss‐of‐function (LOF) variants are causally associated with HSP.
Methods
We analyzed whole‐genome sequencing data from UK Biobank (UKBB), whole‐exome sequencing data from a Canadian HSP cohort (Can‐HSP), and genetic data from the GENESIS cohort—a large international cohort of patients with rare hereditary diseases, including HSP.
Results
Among >170 CPT1C LOF carriers in the UKBB (n = 150,119), none exhibited HSP phenotypes. Among 585 HSP patients from Can‐HSP, we did not find patients with CPT1C LOF variants. In the GENESIS cohort (n = 21,217), three individuals carrying CPT1C LOF variants were also diagnosed with HSP; however, all three also carry pathogenic variants in established HSP‐associated genes.
Conclusions
Our study does not support a causal role for CPT1C LOF variants in HSP. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Québec, Canada.
- Department of Human Genetics, McGill University, Montreal, Québec, Canada.
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
- Divisions of Neurology and Clinical and Metabolic Genetics, Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.
- Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
- Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
ORCID-Profile: Yi-Chung Lee, Giovanni Stevanin, Guy A Rouleau, Ziv Gan-Or
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Zhu, R., Liu, L., Estiar, M. A., Asayesh, F., Ahmad, J., Teferra, M., Yoon, G., Tarnopolsky, M., Boycott, K. M., Dupre, N., Dion, P. A., Suchowersky, O., Jordanova, A., Lee, Y. C., Stevanin, G., Zuchner, S., Rouleau, G. A., & Gan-Or, Z. (2025). Loss‐of‐Function Variants in CPT1C : No Support for a Causal Role in Hereditary Spastic Paraplegia. Movement Disorders. https://doi.org/10.1002/mds.70144
Vancouver
Zhu R, Liu L, Estiar MA, Asayesh F, Ahmad J, Teferra M, et al. Loss‐of‐Function Variants in CPT1C : No Support for a Causal Role in Hereditary Spastic Paraplegia. Movement Disorders. 2025. doi:10.1002/mds.70144
BibTeX
@article{Zhu2025,
author = {Zhu, Rui and Liu, Lang and Estiar, Mehrdad A and Asayesh, Farnaz and Ahmad, Jamil and Teferra, Meron and Yoon, Grace and Tarnopolsky, Mark and Boycott, Kym M and Dupre, Nicolas and Dion, Patrick A and Suchowersky, Oksana and Jordanova, Albena and Lee, Yi-Chung and Stevanin, Giovanni and Zuchner, Stephan and Rouleau, Guy A and Gan-Or, Ziv},
title = {Loss‐of‐Function Variants in CPT1C : No Support for a Causal Role in Hereditary Spastic Paraplegia},
journal = {Movement Disorders},
year = {2025},
doi = {10.1002/mds.70144}
}
EUVIMED